JN AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 85: 468-471, 2001;
0022-3077/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (150)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerdeman, G.
Right arrow Articles by Lovinger, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerdeman, G.
Right arrow Articles by Lovinger, D. M.

The Journal of Neurophysiology Vol. 85 No. 1 January 2001, pp. 468-471
Copyright ©2001 by the American Physiological Society

RAPID COMMUNICATION

CB1 Cannabinoid Receptor Inhibits Synaptic Release of Glutamate in Rat Dorsolateral Striatum

Gregory Gerdeman1 and David M. Lovinger1,2

 1Department of Pharmacology and  2Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37212-0615

Gerdeman, Gregory and David M. Lovinger. CB1 Cannabinoid Receptor Inhibits Synaptic Release of Glutamate in Rat Dorsolateral Striatum. J. Neurophysiol. 85: 468-471, 2001. CB1 cannabinoid receptors in the neostriatum mediate profound motor deficits induced when cannabinoid drugs are administered to rodents. Because the CB1 receptor has been shown to inhibit neurotransmitter release in various brain areas, we investigated the effects of CB1 activation on glutamatergic synaptic transmission in the dorsolateral striatum of the rat where the CB1 receptor is highly expressed. We performed whole cell voltage-clamp experiments in striatal brain slices and applied the CB1 agonists HU-210 or WIN 55,212-2 during measurement of synaptic transmission. Excitatory postsynaptic currents (EPSCs), evoked by electrical stimulation of afferent fibers, were significantly reduced in a dose-dependent manner by CB1 agonist application. EPSC inhibition was accompanied by an increase in two separate indices of presynaptic release, the paired-pulse response ratio and the coefficient of variation, suggesting a decrease in neurotransmitter release. These effects were prevented by application of the CB1 antagonist SR141716A. When Sr2+ was substituted for Ca2+ in the extracellular solution, application of HU-210 (1 µM) significantly reduced the frequency, but not amplitude, of evoked, asynchronous quantal release events. Spontaneous release events were similarly decreased in frequency with no change in amplitude. These findings further support the interpretation that CB1 activation leads to a decrease of glutamate release from afferent terminals in the striatum. These results reveal a novel potential role for cannabinoids in regulating striatal function and thus basal ganglia output and may suggest CB1-targeted drugs as potential therapeutic agents in the treatment of Parkinson's disease and other basal ganglia disorders.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
L. Adermark and D. M Lovinger
Frequency-Dependent Inversion of Net Striatal Output by Endocannabinoid-Dependent Plasticity at Different Synaptic Inputs
J. Neurosci., February 4, 2009; 29(5): 1375 - 1380.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Rossi, V. De Chiara, A. Musella, H. Kusayanagi, G. Mataluni, G. Bernardi, A. Usiello, and D. Centonze
Chronic Psychoemotional Stress Impairs Cannabinoid-Receptor-Mediated Control of GABA Transmission in the Striatum
J. Neurosci., July 16, 2008; 28(29): 7284 - 7292.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Adermark and D. M. Lovinger
Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step
PNAS, December 18, 2007; 104(51): 20564 - 20569.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. L. Niehaus, Y. Liu, K. T. Wallis, M. Egertova, S. G. Bhartur, S. Mukhopadhyay, S. Shi, H. He, D. E. Selley, A. C. Howlett, et al.
CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a
Mol. Pharmacol., December 1, 2007; 72(6): 1557 - 1566.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Cao, L. Liang, J. R. Hadcock, P. A. Iredale, D. A. Griffith, F. S. Menniti, S. Factor, J. T. Greenamyre, and S. M. Papa
Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 318 - 326.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. Centonze, M. Bari, S. Rossi, C. Prosperetti, R. Furlan, F. Fezza, V. De Chiara, L. Battistini, G. Bernardi, S. Bernardini, et al.
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis
Brain, October 1, 2007; 130(10): 2543 - 2553.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. A. Karanian, S. L. Karim, J. T. Wood, J. S. Williams, S. Lin, A. Makriyannis, and B. A. Bahr
Endocannabinoid Enhancement Protects against Kainic Acid-Induced Seizures and Associated Brain Damage
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1059 - 1066.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Singla, A. C. Kreitzer, and R. C. Malenka
Mechanisms for Synapse Specificity during Striatal Long-Term Depression
J. Neurosci., May 9, 2007; 27(19): 5260 - 5264.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Uchigashima, M. Narushima, M. Fukaya, I. Katona, M. Kano, and M. Watanabe
Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum
J. Neurosci., April 4, 2007; 27(14): 3663 - 3676.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
Y. Hashimotodani, T. Ohno-Shosaku, and M. Kano
Endocannabinoids and Synaptic Function in the CNS
Neuroscientist, April 1, 2007; 13(2): 127 - 137.
[Abstract] [PDF]


Home page
J. Physiol.Home page
G. Akopian and J. P. Walsh
Reliable long-lasting depression interacts with variable short-term facilitation to determine corticostriatal paired-pulse plasticity in young rats
J. Physiol., April 1, 2007; 580(1): 225 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. K. Ade and D. M. Lovinger
Anandamide Regulates Postnatal Development of Long-Term Synaptic Plasticity in the Rat Dorsolateral Striatum
J. Neurosci., February 28, 2007; 27(9): 2403 - 2409.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. H. Yin, M. I. Davis, J. A. Ronesi, and D. M. Lovinger
The Role of Protein Synthesis in Striatal Long-Term Depression.
J. Neurosci., November 15, 2006; 26(46): 11811 - 11820.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
I. Freiman, A. Anton, H. Monyer, M. J. Urbanski, and B. Szabo
Analysis of the effects of cannabinoids on identified synaptic connections in the caudate-putamen by paired recordings in transgenic mice
J. Physiol., September 15, 2006; 575(3): 789 - 806.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, S. Batkai, and G. Kunos
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. A. Grueter, H. B. Gosnell, C. M. Olsen, N. L. Schramm-Sapyta, T. Nekrasova, G. E. Landreth, and D. G. Winder
Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration.
J. Neurosci., March 22, 2006; 26(12): 3210 - 3219.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
U. Pagotto, G. Marsicano, D. Cota, B. Lutz, and R. Pasquali
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Endocr. Rev., February 1, 2006; 27(1): 73 - 100.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Engler, I. Freiman, M. Urbanski, and B. Szabo
Effects of Exogenous and Endogenous Cannabinoids on GABAergic Neurotransmission between the Caudate-Putamen and the Globus Pallidus in the Mouse
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 608 - 617.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Andersson, A. Usiello, A. Borgkvist, L. Pozzi, C. Dominguez, A. A. Fienberg, P. Svenningsson, B. B. Fredholm, E. Borrelli, P. Greengard, et al.
Cannabinoid Action Depends on Phosphorylation of Dopamine- and cAMP-Regulated Phosphoprotein of 32 kDa at the Protein Kinase A Site in Striatal Projection Neurons
J. Neurosci., September 14, 2005; 25(37): 8432 - 8438.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. S. Kearn, K. Blake-Palmer, E. Daniel, K. Mackie, and M. Glass
Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk?
Mol. Pharmacol., May 1, 2005; 67(5): 1697 - 1704.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Kofalvi, R. J. Rodrigues, C. Ledent, K. Mackie, E. S. Vizi, R. A. Cunha, and B. Sperlagh
Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum: A Combined Immunochemical and Pharmacological Analysis
J. Neurosci., March 16, 2005; 25(11): 2874 - 2884.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Ronesi and D. M. Lovinger
Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat
J. Physiol., January 1, 2005; 562(1): 245 - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D. A. Fortin, J. Trettel, and E. S. Levine
Brief Trains of Action Potentials Enhance Pyramidal Neuron Excitability Via Endocannabinoid-Mediated Suppression of Inhibition
J Neurophysiol, October 1, 2004; 92(4): 2105 - 2112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. L. Seagard, C. Dean, S. Patel, D. J. Rademacher, F. A. Hopp, W. T. Schmeling, and C. J. Hillard
Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H992 - H1000.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Ronesi, G. L. Gerdeman, and D. M. Lovinger
Disruption of Endocannabinoid Release and Striatal Long-Term Depression by Postsynaptic Blockade of Endocannabinoid Membrane Transport
J. Neurosci., February 18, 2004; 24(7): 1673 - 1679.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. A. Khasabova, C. Harding-Rose, D. A. Simone, and V. S. Seybold
Differential Effects of CB1 and Opioid Agonists on Two Populations of Adult Rat Dorsal Root Ganglion Neurons
J. Neurosci., February 18, 2004; 24(7): 1744 - 1753.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y.-C. Liang, C.-C. Huang, K.-S. Hsu, and T. Takahashi
Cannabinoid-induced presynaptic inhibition at the primary afferent trigeminal synapse of juvenile rat brainstem slices
J. Physiol., February 15, 2004; 555(1): 85 - 96.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. M. Brown, J. M. Brotchie, and S. M. Fitzjohn
Cannabinoids Decrease Corticostriatal Synaptic Transmission via an Effect on Glutamate Uptake
J. Neurosci., December 3, 2003; 23(35): 11073 - 11077.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. L. Colgin, E. A. Kramar, C. M. Gall, and G. Lynch
Septal Modulation of Excitatory Transmission in Hippocampus
J Neurophysiol, October 1, 2003; 90(4): 2358 - 2366.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Patel, D. J. Rademacher, and C. J. Hillard
Differential Regulation of the Endocannabinoids Anandamide and 2-Arachidonylglycerol within the Limbic Forebrain by Dopamine Receptor Activity
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 880 - 888.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. R. Leker, N. Gai, R. Mechoulam, and H. Ovadia
Drug-Induced Hypothermia Reduces Ischemic Damage: Effects of the Cannabinoid HU-210
Stroke, August 1, 2003; 34(8): 2000 - 2006.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. F. FREUND, I. KATONA, and D. PIOMELLI
Role of Endogenous Cannabinoids in Synaptic Signaling
Physiol Rev, July 1, 2003; 83(3): 1017 - 1066.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. F. Hoffman, M. Oz, T. Caulder, and C. R. Lupica
Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure
J. Neurosci., June 15, 2003; 23(12): 4815 - 4820.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Rademacher, S. Patel, F. A. Hopp, C. Dean, C. J. Hillard, and J. L. Seagard
Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1570 - H1576.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Rawls, A. Cowan, R. J. Tallarida, E. B. Geller, and M. W. Adler
N-Methyl-D-aspartate Antagonists and WIN 55212-2 [4,5-Dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a Cannabinoid Agonist, Interact to Produce Synergistic Hypothermia
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 395 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Gubellini, B. Picconi, M. Bari, N. Battista, P. Calabresi, D. Centonze, G. Bernardi, A. Finazzi-Agro, and M. Maccarrone
Experimental Parkinsonism Alters Endocannabinoid Degradation: Implications for Striatal Glutamatergic Transmission
J. Neurosci., August 15, 2002; 22(16): 6900 - 6907.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. Trettel and E. S. Levine
Cannabinoids Depress Inhibitory Synaptic Inputs Received by Layer 2/3 Pyramidal Neurons of the Neocortex
J Neurophysiol, July 1, 2002; 88(1): 534 - 539.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Mauler, J. Mittendorf, E. Horvath, and J. de Vry
Characterization of the Diarylether Sulfonylester (-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a Potent Cannabinoid Receptor Agonist with Neuroprotective Properties
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 359 - 368.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. C. Howlett, F. Barth, T. I. Bonner, G. Cabral, P. Casellas, W. A. Devane, C. C. Felder, M. Herkenham, K. Mackie, B. R. Martin, et al.
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Pharmacol. Rev., June 1, 2002; 54(2): 161 - 202.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C.-C. Huang, Y.-L. Chen, S.-W. Lo, and K.-S. Hsu
Activation of cAMP-Dependent Protein Kinase Suppresses the Presynaptic Cannabinoid Inhibition of Glutamatergic Transmission at Corticostriatal Synapses
Mol. Pharmacol., March 1, 2002; 61(3): 578 - 585.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
S. Kelly and V. Chapman
Selective Cannabinoid CB1 Receptor Activation Inhibits Spinal Nociceptive Transmission In Vivo
J Neurophysiol, December 1, 2001; 86(6): 3061 - 3064.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online